Indeed, serum levels of Sp17 autoantibodies exhibited a significant positive correlation with serum levels of osteocalcin and β-CTx in patients with active SAPHO syndrome, which suggested serum levels of Sp17 autoantibodies are associated with osteoarthritis and osteolytic lesions. Here, BGLAP is linked to SAPHO syndrome.